ada.enesco, Author at European Medical Journal - Page 18 of 27

Which Treatment for Malignant Pleural Effusions Works Best?

No difference in mortality found between indwelling pleural catheters and chemical pleurodesis for treating malignant pleural effusions.

New Study Evaluates VR/AR Headset Accuracy in Diagnosing Diverticulitis

VR/AR headsets could one day match desktops in diagnostic effectiveness, according to a recent study.

Meta-Analysis Reveals Impact of Hypotension on TBI Mortality

Patients with traumatic brain injury (TBI) and hypotension face doubled mortality odds, highlighting the need for precise blood pressure management in clinical practice.

Does Retreating Multiple Myeloma with Previously Refractory Drugs Work?

Patients with late line relapsed/refractory multiple myeloma (RRMM) could benefit from repeat treatment with drugs their disease has previously been refractory to.

GLP-1 Agonists May Help Reduce Alcohol-Related Hospitalisations

Glucagon-like peptide-1 receptor (GLP-1) agonists, particularly semaglutide, could be effective in reducing alcohol-related hospitalisations.

Low-Dose IL-2 Shows Promise for Allergic Rhinitis Relief

In the trial, patients received either IL-2 (1 MUI/day) or a placebo for 5 days, followed by weekly doses for 4 weeks.

Targeted Hepatitis C Efforts Show Promising Results in Spain

In Spain, HCV prevalence among people experiencing homelessness has declined significantly, from 7.2% in 2019 to 3.4% in 2023.

Suture Alone or with Plug? Trial Reveals Superior Strategy for Vascular Access

The ACCESS-TAVI trial demonstrated that a combined suture/plug-based vascular closure device strategy significantly reduces vascular complications and bleeding events.

High Pain Interference Persists in Children with Juvenile Arthritis

Significant pain interference affects many children with juvenile idiopathic arthritis, with fatigue and mobility playing key roles, a new study finds.

Vasomotor Symptoms During Menopause Increase Diabetes Risk

This study suggests that frequent or persistent VMS during the MT may signal an elevated risk of diabetes, identifying a high-risk group for targeted diabetes prevention.